Publication Name	World Journal of Gastroenterology
Manuscript ID	18947
Country	Iran

Received	2015-04-29 13:47
Peer-Review Started	2015-05-07 09:28
To Make the First Decision	2015-06-02 15:12
Return for Revision	2015-06-09 12:47
Revised	2015-07-19 04:14
Second Decision	2015-09-12 22:02
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-14 11:31
Articles in Press	2015-09-14 11:32
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-09-28 09:39
Typeset the Manuscript	2015-10-22 19:56
Publish the Manuscript Online	2015-11-11 13:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Topic Highlights
Article Title	Progress in the development of vaccines for hepatitis C virus infection
Manuscript Source	Invited Manuscript
All Author List	Faezeh Ghasemi, Sina Rostami and Zahra Meshkat
Funding Agency and Grant Number
Corresponding Author	Zahra Meshkat, PhD, Antimicrobial Resistance Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9196773117, Iran. meshkatz@mums.ac.ir
Key Words	Preventive vaccine; Therapeutic vaccine; Hepatitis C virus; Hepatitis C virus infection
Core Tip	Chronic hepatitis C virus (HCV) infection occurs in about 75%-90% of acutely infected individuals. It may progress to liver cirrhosis or hepatocellular carcinoma. Despite satisfactory progress in the management and treatment of chronic hepatitis C, it remains one of the most prominent viral infections worldwide. Although no reliable vaccine for it has yet been developed, researchers are trying to design and develop different types of vaccines to prevent HCV infection or to cure the chronic form of the disease. The current article provides an overview of the latest progress in the development of preventive and therapeutic vaccines against HCV infection in the context of peptide vaccines, recombinant protein vaccines, HCV-like particle, DNA vaccines, and viral vectors expressing HCV genes.
Publish Date	2015-11-11 13:34
Citation	Ghasemi F, Rostami S, Meshkat Z. Progress in the development of vaccines for hepatitis C virus infection. World J Gastroenterol 2015; 21(42): 11984-12002
URL	http://www.wjgnet.com/1007-9327/full/v21/i42/11984.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i42.11984

Full Article (PDF)	WJG-21-11984.pdf
Full Article (Word)	WJG-21-11984.doc
Manuscript File	18947-Review.docx
Answering Reviewers	18947-Answering reviewers.pdf
Audio Core Tip	18947-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18947-Conflict-of-interest statement.pdf
Copyright License Agreement	18947-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18947-Language certificate.pdf
Peer-review Report	18947-Peer-review(s).pdf
Scientific Misconduct Check	18947-Scientific misconduct check.pdf
Scientific Editor Work List	18947-Scientific editor work list.pdf